Cargando…
What Affects Treatment Underuse in Multiple Myeloma in the United States: A Qualitative Study
SIMPLE SUMMARY: Multiple myeloma is the second most common hematologic malignancy. Diagnosis, treatment, and survival rates vary by race, which suggests that race may influence access to or reception of treatment. This study sought to understand multiple myeloma patients’ treatment experiences and f...
Autores principales: | Cytryn, Rose, Bickell, Nina, Yagnik, Radhi, Jagannath, Sundar, Lin, Jenny J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137271/ https://www.ncbi.nlm.nih.gov/pubmed/37190297 http://dx.doi.org/10.3390/cancers15082369 |
Ejemplares similares
-
Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States
por: Jagannath, Sundar, et al.
Publicado: (2022) -
Recent progress in the treatment of multiple myeloma: updates and highlights from ASH 2008
por: Jagannath, Sundar
Publicado: (2009) -
Proteasome inhibition and its therapeutic potential in multiple myeloma
por: Chari, Ajai, et al.
Publicado: (2010) -
Genetic rescue remains underused for aiding recovery of federally listed vertebrates in the United States
por: Fitzpatrick, Sarah W, et al.
Publicado: (2023) -
Recent Advances in the Understanding and Treatment of Multiple Myeloma
por: Cook, Richard, et al.
Publicado: (2008)